Fabrication of dual stimuli-responsive multicompartmental drug carriers for tumor-selective drug release

Hyeon Ung Kim, Dae Gun Choi, Hyunjee Lee, Min Suk Shim, Ki Wan Bong

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

There has been increasing attention to the development of multi-stimuli-responsive drug carriers for precisely controlled drug release at target disease areas. In this study, pH- and redox-responsive hybrid drug carriers were fabricated by using both ketal-based acid-cleavable precursors and disulfide-based reducible precursors via stop-flow lithography. pH- and redox-sensitive drug release of the dual stimuli-responsive hybrid particles was confirmed, demonstrating their feasibility for selective and efficient drug release into tumor tissues in acidic and highly reductive environments. It was also found that the drug release rate of the particles was fine-tuned by modulating monomer compositions in the precursor. Importantly, the dual stimuli-responsive hybrid particles exhibited synergistic, controlled drug release in complex stimuli (both pH and redox stimuli) environments. To achieve tumor-selective combination chemotherapy, multicompartmental drug carriers consist of an acid-degradable compartment and a reducible compartment, which can separately encapsulate individual model drugs in each of the compartments. The multicompartmental particles exhibited independent drug release upon exposure to the corresponding stimulus. The dual stimuli-responsive, multicompartmental particles are effective drug carriers for tumor-selective release of a drug cocktail, leading to synergistic combination chemotherapy.

Original languageEnglish
Pages (from-to)754-764
Number of pages11
JournalLab on a chip
Volume18
Issue number5
DOIs
Publication statusPublished - 2018 Mar 7

ASJC Scopus subject areas

  • Bioengineering
  • Biochemistry
  • Chemistry(all)
  • Biomedical Engineering

Fingerprint Dive into the research topics of 'Fabrication of dual stimuli-responsive multicompartmental drug carriers for tumor-selective drug release'. Together they form a unique fingerprint.

Cite this